|Last Price$125.64||Day Change (%)0.62%|
|Open Price$124.56||Day Change ($)0.77|
|Day Range123.27–125.77||52-Week Range107.33–131.12|
As of Mon 01/26/2015 05:19 PM EST | USD
Research and Markets: Global Transfection Technologies Market 2015-2019 with Bio-Rad Laboratories, Maxcyte, Polyplus Transfection, Promega & Thermo Fisher Scientific Dominating
These unloved stocks may beat the S&P 500 again in 2015
Research and Markets: Global Infectious Disease Diagnostics Market 2014-2019 - Product, Application, Technology & End User Analysis of the $18 Billion Industry
Research and Markets: Digital PCR Market Research Report - 2014-2020 Global Industry Analysis
Continued technology advancements and market expansion support Illumina's narrow moat.
A group of top managers continue to keep looking for good investment opportunities, while taking full advantage of a rising (and potentially overvalued) market to book some gains.
Top managers continue to exercise a lot of patience as they look for buying opportunities in a U.S. equity market that has risen close to 40% since the start of 2013.
DNAe Acquires nanoMR Inc. in a Strategic Move to Own Complete Workflow for Point-Of-Need NGS-Based Blood-To-Result Diagnostic